IRIS
FEDERICO, Alessandro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 24.950
NA - Nord America 11.325
AS - Asia 9.671
SA - Sud America 1.847
AF - Africa 151
OC - Oceania 28
Continente sconosciuto - Info sul continente non disponibili 5
Totale 47.977
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 15.583
US - Stati Uniti d'America 11.111
SG - Singapore 3.645
IE - Irlanda 2.406
IT - Italia 1.997
CN - Cina 1.924
BR - Brasile 1.527
HK - Hong Kong 1.497
UA - Ucraina 1.285
VN - Vietnam 1.133
GB - Regno Unito 1.052
DE - Germania 617
FI - Finlandia 499
FR - Francia 464
SE - Svezia 384
KR - Corea 332
TR - Turchia 289
GR - Grecia 257
IN - India 220
JP - Giappone 205
AR - Argentina 132
NL - Olanda 88
AT - Austria 87
MX - Messico 80
CA - Canada 74
BD - Bangladesh 72
PL - Polonia 63
IQ - Iraq 57
EC - Ecuador 55
ID - Indonesia 54
ZA - Sudafrica 49
ES - Italia 45
BE - Belgio 37
PK - Pakistan 34
AU - Australia 27
CO - Colombia 26
IR - Iran 26
PY - Paraguay 24
VE - Venezuela 23
UZ - Uzbekistan 22
PE - Perù 19
CL - Cile 18
EG - Egitto 18
MA - Marocco 17
MY - Malesia 17
SA - Arabia Saudita 17
AZ - Azerbaigian 15
DZ - Algeria 15
CZ - Repubblica Ceca 14
DO - Repubblica Dominicana 14
TH - Thailandia 14
TN - Tunisia 13
KE - Kenya 12
KZ - Kazakistan 12
UY - Uruguay 12
NP - Nepal 11
BO - Bolivia 10
LT - Lituania 9
TW - Taiwan 9
HN - Honduras 8
JM - Giamaica 8
JO - Giordania 8
AL - Albania 7
ET - Etiopia 7
IL - Israele 7
MK - Macedonia 7
PT - Portogallo 7
TT - Trinidad e Tobago 7
CR - Costa Rica 6
LK - Sri Lanka 6
RO - Romania 6
SN - Senegal 6
AE - Emirati Arabi Uniti 5
BG - Bulgaria 5
CH - Svizzera 5
GE - Georgia 5
GT - Guatemala 5
NO - Norvegia 5
CY - Cipro 4
DK - Danimarca 4
KG - Kirghizistan 4
PA - Panama 4
PH - Filippine 4
PS - Palestinian Territory 4
AM - Armenia 3
BA - Bosnia-Erzegovina 3
CI - Costa d'Avorio 3
EU - Europa 3
HR - Croazia 3
NG - Nigeria 3
OM - Oman 3
AO - Angola 2
BB - Barbados 2
BY - Bielorussia 2
HU - Ungheria 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
MO - Macao, regione amministrativa speciale della Cina 2
NI - Nicaragua 2
Totale 47.951
Salva come PNG Salva come JPEG
Città #
Moscow 5.525
Dublin 2.400
Jacksonville 1.913
Hong Kong 1.472
Singapore 1.462
Santa Clara 1.270
Chandler 1.229
San Jose 1.006
Ashburn 499
Ho Chi Minh City 383
Princeton 377
Roxbury 311
Seoul 310
Beijing 296
Naples 292
Hefei 247
Hanoi 246
Ann Arbor 223
Cambridge 220
Boardman 205
New York 188
Medford 168
Dallas 161
Wilmington 158
Helsinki 149
Woodbridge 138
The Dalles 131
Bengaluru 118
São Paulo 107
Caserta 99
Munich 93
Des Moines 89
Los Angeles 87
Rome 86
Houston 79
San Mateo 77
Da Nang 66
Mountain View 66
Nanjing 63
Milan 62
Bremen 60
Dong Ket 54
Nuremberg 53
Orem 48
Haiphong 46
Amsterdam 45
Vienna 44
Council Bluffs 42
Düsseldorf 40
Napoli 40
Belo Horizonte 39
Tokyo 38
Rio de Janeiro 36
Brussels 33
Jinan 33
Kraków 33
Shanghai 32
Aversa 31
Brasília 31
Frankfurt am Main 31
Porto Alegre 31
Turku 31
Tianjin 30
Norwalk 29
Atlanta 28
Bologna 28
Curitiba 28
Paris 28
Shenyang 28
Guangzhou 27
Potenza 26
Biên Hòa 25
Chennai 22
Falkenstein 22
Guayaquil 22
London 22
Tashkent 22
Auburn Hills 21
Chicago 21
Johannesburg 21
Bari 20
Thái Bình 20
Boydton 19
Manchester 19
Brooklyn 18
Campinas 18
San Francisco 18
Dhaka 17
Manaus 17
Quito 17
Salvador 17
Hangzhou 16
Mexico City 16
Mumbai 16
Warsaw 16
Baku 15
Buenos Aires 15
Duhok 15
Hải Dương 15
Nanchang 15
Totale 23.731
Salva come PNG Salva come JPEG
Nome #
Sleisenger e Fordtran. Malattie gastrointestinali ed epatiche. Fisiopatologia, diagnosi e trattamento 364
A Long-term Treatment with Silybin in Patients with Non-alcoholic Steatohepatitis Stimulates Catalase Activity in Human Endothelial Cells 218
Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma and Child-Pugh A or B cirrhosis 208
Integrating Silybin and Sirtuin Related Pathways in Steatosis-Related Liver Diseases 193
Intrafamilial spread of Helicobacter pylori infection 192
Silybin for the treatment of metabolic oxidative alterations in patients with non-alcoholic steatohepatitis (NASH) 189
Endocan Serum Levels in Patients with Non-Alcoholic Fatty Liver Disease with or without Type 2 Diabetes Mellitus: A Pilot Study 181
A "systems medicine" approach to the study of non-alcoholic fatty liver disease 179
Espressione del recettore dell’urotensina-II nell’adenocarcinoma del colon umano: studi in vitro ed in vivo. 178
Helicobacter pylory infection but not small intestinal bacterial overgrowth may play a pathogenic role in rosacea. 176
14-Day, High-Dose Acid Suppression, Non-Bismuth Quadruple Therapies (Hybrid vs. Concomitant) for Helicobacter pylori Infection: A Randomized Trial 176
Adherence and Effects Derived from FODMAP Diet on Irritable Bowel Syndrome: A Real Life Evaluation of a Large Follow-Up Observation 176
Autoimmune thyroid disease and neuroendocrine gastric tumors: early detection and efficacy of somatostatin analogue treatment. 175
A pilot study on the ability of clinoptilolite to absorb ethanol in vivo in healthy drinkers: effect of gender 171
A 60-Year-Old Woman with Primary Biliary Cholangitis and Crohn's Ileitis Following the Suspension of Ursodeoxycholic Acid 170
Silybin-Induced Apoptosis Occurs in Parallel to the Increase of Ceramides Synthesis and miRNAs Secretion in Human Hepatocarcinoma Cells 170
Chronic inflammation and oxidative stress in human carcinogenesis 169
Alcohol and pathologies of the gastrointestinal tract, liver and pancreas 169
A probiotic treatment ameliorates CCl4-induced liver fibrosis in rats. 169
Crohn’s disease and skin 168
Validity and reliability of the Italian version of the Chronic Liver Disease Questionnaire (CLDQ-I) for the assessment of health-related quality of life 168
A case of hepatotoxicity caused by green tea 165
Antioxidant effects of Silybin, Silybin-phosphatidylcholine complex, and derivatives of Silibinin on in vitro cultured cells damaged by oxidative stress 164
Just Drink a Glass of Water? Effects of Bicarbonate-Sulfate-Calcium-Magnesium Water on the Gut-Liver Axis 163
Alcoholic beverages and gastric epithelial cell viability: effect on oxidative stress-induced damage 163
Ameliorative effect of Silybin on bisphenol A induced oxidative stress, cell proliferation and steroid hormones oxidation in HepG2 cell cultures 162
Alteration of haemostasis in non-metastatic gastric cancer 161
A Facebook survey to obtain alcohol-related information by young people and adolescents. An Italian study 161
Composizione per il trattamento della sindrome metabolica e delle alterazioni metabolico-ossidative nei pazienti con steatoepatite non alcolica (NASH) 161
Telaprevir may induce adverse cutaneous reactions by a T cell immune-mediated mechanism 160
A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort 158
May chronic cough in chronic obstructive pulmonary disease be a contraindication of Percutaneous Endoscopic Gastrostomy placement: a case report 158
Polydatin administration improves serum biochemical parameters and oxidative stress markers during chronic alcoholism: a pilot study 157
Attività citotossica della silibina su linee cellulari tumorali umane del tratto gastro-intestinale. 157
Evaluation of the Effect Derived from Silybin with Vitamin D and Vitamin E Administration on Clinical, Metabolic, Endothelial Dysfunction, Oxidative Stress Parameters, and Serological Worsening Markers in Nonalcoholic Fatty Liver Disease Patients 157
Long-term use of human albumin for the treatment of ascites in patients with hepatic cirrhosis: the interim analysis of the ANSWER study 156
Oral microbiota and salivary levels of oral pathogens in gastro‐intestinal diseases: Current knowledge and exploratory study 156
BNT162b2 mRNA COVID-19 vaccine is safe in a setting of patients on biologic therapy with inflammatory bowel diseases: a monocentric real-life study 155
Activated protein C resistance in nonmetastatic gastric cancer patients. 154
Hericium erinaceus, a medicinal fungus with a centuries-old history: Evidence in gastrointestinal diseases 152
'' Non alcoholic fatty liver disease and eNOS dysfunction in humans '' 151
Real-life glecaprevir/pibrentasvir in a large cohort of patients with hepatitis C virus infection: The MISTRAL study 151
A Combination of Microarray-Based Profiling and Biocomputational Analysis Identified miR331-3p and hsa-let-7d-5p as Potential Biomarkers of Ulcerative Colitis Progression to Colorectal Cancer 150
Alcoholic Consumption of Young Italians During the SARS-CoV-2 Pandemic 150
Urotensin-II receptor expression in human colon adenocarcinoma: in vitro and in vivo studies. 150
Gastrointestinal Hormones, Intestinal Microbiota and Metabolic Homeostasis in Obese Patients: Effect of Bariatric Surgery 150
Aggregazione piastrinica in pazienti con epatite cronica da HCV: studi in vitro. 149
AISF position paper on liver disease and pregnancy 149
Helicobacter pylori second-line rescue therapy with levofloxacin- and bismuth-containing quadruple therapy, after failure of standard triple or non-bismuth quadruple treatments 148
A real-life study of new antiviral therapies in a high prevalence geographical area for hepatitis C virus infection 148
Tenofovir disoproxil fumarate monotherapy maintains HBV suppression achieved by a "de novo" combination of lamivudine-adefovir: a pilot study 147
Amelanotic metastatic melanoma of the stomach presenting with iron deficiency anemia 147
Carcinogenesis as a Result of Multiple Inflammatory and Oxidative Hits: a Comprehensive Review from Tumor Microenvironment to Gut Microbiota 146
Gut microbiota correlates with antitumor activity in patients with mCRC and NSCLC treated with cetuximab plus avelumab 146
A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease 145
Comparsa di pancreatite acuta ed epatite autoimmune in corso di trattamento con IFN: descrizione di un caso clinico. 145
The bisphenol a induced oxidative stress in non-alcoholic fatty liver disease male patients: A clinical strategy to antagonize the progression of the disease 143
Advanced liver disease outcomes after hepatitis C eradication by human immunodeficiency virus infection in PITER cohort 143
Evaluation of the Efficacy and Safety of a Compound of Micronized Flavonoids in Combination With Vitamin C and Extracts of Centella asiatica, Vaccinium myrtillus, and Vitis vinifera for the Reduction of Hemorrhoidal Symptoms in Patients With Grade II and III Hemorrhoidal Disease: A Retrospective Real-Life Study 143
Anorectal Function with High-Resolution Anorectal Manometry in Active Ulcerative Colitis and after Remission: A Pilot Study 142
Skin Adverse Events During Dual And Triple Therapy For HCV-Related Cirrhosis 142
How immunotherapy has changed the continuum of care in hepatocellular carcinoma 142
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 141
Targeting the gut-brain axis for therapeutic adherence in patients with inflammatory bowel disease: a review on the role of psychotherapy 140
A new silybin-vitamin E-phospholipid complex improves insulin resistance and liver damage in patients with non-alcoholic fatty liver disease: preliminary observations 140
Non-bismuth and bismuth quadruple therapies based on previous clarithromycin exposure are as effective and safe in an area of high clarithromycin resistance: A real-life study 140
An Italian survey on dietary habits and changes during the COVID-19 lockdown 140
The urotensin-II receptor: A marker for staging and steroid outcome prediction in ulcerative colitis 139
Urotensin-II receptor: a new marker for the differentiation and the target in colon cancer? 139
The use of bicarbonate-sulphate-calcium-magnesium and sodium-low drinkable water improves functional gastrointestinal symptoms in patients with non-alcoholic fatty liver disease: A prospective study 138
Urotensin-II receptor is over-expressed in colon cancer cell lines and in colon carcinoma in humans. 138
Chemical effect of bisphenol a on non-alcoholic fatty liver disease 138
Alcohol abuse affects nitric oxide production in patients with chronic liver disease. 136
Qualitative and quantitative evaluation of gut microbial populations in severely obese patients following bilio-intestinal bypass 136
The Lesson from the First Italian Lockdown: Impacts on Anxiety and Depressive Symptoms and Sleep Quality in Patients with Remission of Inflammatory Bowel Disease 136
Light alcohol drinking and the risk of cancer development: a controversial relationship 135
The JAK-STAT Pathway as a Therapeutic Strategy in Cancer Patients with Immune Checkpoint Inhibitor-Induced Colitis: A Narrative Review 134
ITPase activity modulates the severity of anaemia in HCV-related cirrhosis treated with ribavirin-containing interferon-free regimens. 132
Qualitative and Quantitative Evaluation of Dietary Intake in Patients with Non-Alcoholic Steatohepatitis 132
Angiografia perfusionale con mdc di 2a generazione nella valutazione della efficacia necrotica delle terapie ablative percutanee (PAT): studio prospettico vs TC spirale. 131
The Melanocortin System in Inflammatory Bowel Diseases: Insights into Its Mechanisms and Therapeutic Potentials 130
Vedolizumab as Rescue Therapy in Carboplatin-Gemcitabine-Induced Triggered Acute Severe Ulcerative Colitis Flare-Up 130
Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial 130
Cause di malnutrizione nel paziente neoplastico 130
Alcohol associated liver disease 2020: A clinical practice guideline by the Italian Association for the Study of the Liver (AISF) 130
Regorafenib in combination with silybin as a novel potential strategy for the treatment of metastatic colorectal cancer 130
Hericium erinaceus, in combination with natural flavonoid/alkaloid and B3/B8 vitamins, can improve inflammatory burden in Inflammatory bowel diseases tissue: an ex vivo study 129
Trace elements and chronic liver diseases 129
Silybin–Phosphatidylcholine Complex Protects Human Gastric and Liver Cells from Oxidative Stress 129
Dysgeusia in MASLD-related advanced chronic liver disease (ACLD): a silent driver towards the "Bermuda" triangle of malnutrition-sarcopenia-frailty severely affecting prognosis 128
Urotensin II receptor expression in patients with ulcerative colitis: a pilot study 127
Red cell distribution width/platelet ratio estimates the 3-year risk of decompensation in Metabolic Dysfunction-Associated Steatotic Liver Disease-induced cirrhosis 127
Charting new AI education in gastroenterology: Cross-sectional evaluation of ChatGPT and perplexity AI in medical residency exam 126
Are Small Molecules Effective in Treating Inflammatory Pouch Disorders Following Ileal Pouch-Anal Anastomosis for Ulcerative Colitis? Here Is Where We Stand 126
Obesità androide postmenopausale: ruolo del DHEA-S, didrotestosterone libero ed SHBG. 126
May ChatGPT be a tool producing medical information for common inflammatory bowel disease patients’ questions? An evidence-controlled analysis 125
Systemic Oxidative Balance Reflects the Liver Disease Progression Status for Primary Biliary Cholangitis (Pbc): The Narcissus Fountain 124
Considering a Janus kinase inhibitor in patients with concomitant ulcerative colitis and hidradenitis suppurativa/acne inversa: is it really a gamble? Hints from a case report 124
Role of Non-Coding RNAs in Hepatocellular Carcinoma Progression: From Classic to Novel Clinicopathogenetic Implications 124
Hashimoto’s thyroiditis and entero-chromaffin-like cell hyperplasia: early detection and somatostatin analogue treatment. 124
Totale 15.219
Salva come PNG Salva come JPEG
Categoria #
all - tutte 155.266
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 155.266
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021909 0 0 0 0 0 0 0 0 0 387 363 159
2021/20222.232 94 20 27 67 782 32 54 60 88 63 204 741
2022/20234.576 446 120 49 373 453 373 17 304 2.223 44 81 93
2023/20242.091 155 69 78 151 684 169 55 58 35 68 204 365
2024/20256.365 52 78 147 232 1.045 578 728 548 766 1.333 482 376
2025/202625.451 875 1.152 1.403 1.357 2.090 14.602 1.350 1.086 1.061 475 0 0
Totale 48.529